Ad is loading...
LRSQX
Price
$15.52
Change
-$0.14 (-0.89%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

LRSQX vs VISVX

Header iconLRSQX vs VISVX Comparison
Open Charts LRSQX vs VISVXBanner chart's image
Lord Abbett Small Cap Value R2
Price$15.52
Change-$0.14 (-0.89%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
LRSQX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LRSQX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRSQX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. LRSQX (422M). VISVX pays higher dividends than LRSQX: VISVX (1.90) vs LRSQX (0.00). LRSQX was incepted earlier than VISVX: LRSQX (17 years) vs VISVX (27 years). LRSQX is a more actively managed with annual turnover of: 34.00 vs. VISVX (16.00). LRSQX has a lower initial minimum investment than VISVX: LRSQX (0) vs VISVX (3000). LRSQX annual gain was more profitable for investors over the last year : 31.19 vs. VISVX (28.71). VISVX return over 5 years is better than : 57.32 vs. LRSQX (-3.66).
LRSQXVISVXLRSQX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years27 years-
Gain YTD17.30915.433112%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets422M57.6B1%
Annual Yield % from dividends0.001.90-
Returns for 1 year31.1928.71109%
Returns for 3 years-9.9213.23-75%
Returns for 5 years-3.6657.32-6%
Returns for 10 years-52.86108.21-49%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics